Zytiga (abiraterone acetate)

Block 1

Zytiga (Abiraterone Acetate) distributor

Zytiga (Abiraterone Acetate) distributor, wholesaler, supplier

DESCRIPTION:

Abiraterone acetate, the active ingredient of ZYTIGA is the acetyl ester of abiraterone. Abiraterone is an inhibitor of CYP17 (17α-hydroxylase/C17,20-lyase). Each ZYTIGA tablet contains either 250 mg or 500 mg of abiraterone acetate.

ZYTIGA (ABIRATERONE ACETATE) INDICATIONS:

ZYTIGA is indicated in combination with prednisone for the treatment of patients with:

  • Metastatic castration-resistant prostate cancer (CRPC)
  • Metastatic high-risk castration-sensitive prostate cancer (CSPC)

DOSAGE FORM & STRENGTH:

  • Zytiga (abiraterone acetate) 250mg
  • Zytiga (abiraterone acetate) 500mg

Rasso Swiss Pharma is a Wholesaler, supplier and distributor for Zytiga (abiraterone acetate). 

<< Back to products